Adelphi Real World

Adelphi Real World designs and conducts non-interventional/observational studies for pharmaceutical and biotechnology companies. Comprising of PhDs, Masters, technical expertise and CRA experience, the team prides itself on scientifically and ethically robust studies, typically investigating the following themes across a range of therapy areas:
- Healthcare resource utilisation/cost of illness
- Guideline adherence
- Health related quality of life (HRQoL) and Other patient-reported outcomes
- Caregiver burden
- Clinical outcomes
- Treatment patterns.
As part of Adelphi Real World, the team draws upon 20 years of multinational real-world study experience in over 50 diseases in collaboration with Health Economics and Outcomes Research and statistical expertise. We have extensive experience in database analyses, accessing and merging data across Europe, North America, and Asia Pacific for use in epidemiology and burden of illness analyses.